Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Ningning Liu(Shuguang Hospital), Qi Li(First Affiliated Hospital of Zhengzhou University), Jiege Huo(Nanjing University of Chinese Medicine), Huaimin Liu(Shanghai University of Traditional Chinese Medicine), Wanli Deng(Shanghai University of Traditional Chinese Medicine), Qing Ji(Shanghai University of Traditional Chinese Medicine), Yuanyuan Feng(Shanghai University of Traditional Chinese Medicine), Haijuan Xiao(Wenzhou Hospital of Traditional Chinese Medicine), Guoxiang Cai(Shanghai Medical College of Fudan University), Yan Wang(Harbin University of Commerce), Chaojun Wu(Shanghai University of Traditional Chinese Medicine), Ru Jia(Shanghai University of Traditional Chinese Medicine), Hua Sui(Shanghai Jiao Tong University), Lihong Zhou(Jiangnan University), Puhua Zeng(Hunan Academy of Traditional Chinese Medicine)
Frontiers in Pharmacology
April 21, 2020
10.3389/fphar.2020.00478
Cited by 41

Related Papers

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
|BMC Cancer|2008|393
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
|Cell Metabolism|2018|305
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation
|Nature Communications|2020|284
Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway
|PLoS ONE|2015|177